The presence of Zoetis Ruminants at the ANEMBE 2025 Congress left an indelible mark on the veterinary sector. With more than 800 veterinarians registered, the Europa Congress Palace in Vitoria-Gasteiz became the epicenter of innovation in bovine health, with Protivity® as the central axis of its innovative proposal.
The symposium organized by Zoetis on May 29 brought together 120 attendees, becoming one of the highlights of the Congress.
Under the title “Implementation of a Control and Monitoring Program for BRD on Cattle Farms,” top-level experts shared the latest advances in the prevention, diagnosis, and treatment of Bovine Respiratory Diseases (BRD).
Presentations that made a difference
Among the most notable interventions, Jose María San Miguel presented effective strategies for BRD control, while Francisco Javier García Peña showcased innovative diagnostic methods. On the other hand, Juan Rodríguez and Eugenia Peralta shared the first experiences with Protivity® in preventive programs, highlighting its impact in the United States and Spain.
Protivity®, the change against M. bovis
The presence of Zoetis at ANEMBE 2025 had Protivity® as its central axis, a revolutionary tool that is transforming cattle health. Veterinarians from all over Spain learned firsthand how this modified live vaccine against Mycoplasma bovis effectively prevents one of the main threats to bovine health. With Protivity®, Zoetis reaffirms its commitment to animal health, offering professionals in the sector the opportunity to promote change against M. bovis and ensure a healthier and more profitable future for farms.
A memorable Congress
The ANEMBE 2025 Congress, which brought together nearly 800 veterinarians, once again established itself as a benchmark in the exchange of knowledge and progress in animal health. Zoetis is proud to have been part of this prestigious event, bringing innovation, experience, and solutions to the heart of the sector.
About Zoetis
As a world leader in animal health, Zoetis is guided by a unique purpose: to care for the world and people through innovation in animal health and welfare. After more than 70 years of innovating ways to predict, prevent, detect, and treat animal diseases, Zoetis continues to support those who raise and care for animals worldwide, from farmers to veterinarians and pet owners. The company’s main product portfolio, which includes medicines, vaccines, diagnostics, and technologies, makes a difference in more than 100 countries. Zoetis, a Fortune 500 company, generated revenues of $9.3 billion in 2024 and has approximately 13,800 employees.
Continue reading this content
Register for free or log in to access all rumiNews content.
